AssetMark Inc’s Cellcom Israel, Ltd. CEL Stock Holding History

AssetMark Inc’s Portfolio CEL Stock Details CEL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q2	–	Sell	-21	Closed	–	–	1519
2017 Q1	$0	Buy	+21	New	+$216	﹤0.01%	1501

Other funds holding CEL

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Clal Insurance Tel-Aviv, Israel $16.6B AUM 68.34% 1-Year Est. Return

Jane Street New York $777B AUM 61.18% 1-Year Est. Return

Swiss National Bank Zurich, Switzerland $174B AUM 30.96% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

EGA

Eagle Global Advisors Houston, Texas $2.78B AUM 26.09% 1-Year Est. Return

Grantham, Mayo, Van Otterloo & Co (GMO) Boston, Massachusetts $39.1B AUM 28.69% 1-Year Est. Return

Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return

AssetMark Inc's CEL Position: Q2 2017 in Review

AssetMark Inc sold out of Cellcom Israel, Ltd. (CEL) in Q2 2017, closing a stake of 21 shares.

AssetMark Inc first reported a position in CEL in Q1 2017 and held it in 1 quarter. The position peaked at $0 in Q1 2017. 38 funds tracked by Wall St. Rank hold CEL as of Q2 2017.

AssetMark Inc reported no remaining Cellcom Israel, Ltd. position as of Q2 2017 after selling out during the quarter.
AssetMark Inc sold 21 Cellcom Israel, Ltd. shares in Q2 2017.
AssetMark Inc first reported a position in Cellcom Israel, Ltd. in Q1 2017 and held it in 1 quarter.
AssetMark Inc's Cellcom Israel, Ltd. position peaked at $0 in Q1 2017.
38 funds tracked by Wall St. Rank held Cellcom Israel, Ltd. as of Q2 2017.

Based on AssetMark Inc's 13F filing for Q2 2017, filed 15 Aug 2017.